News
(Reuters) -The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 ...
(Reuters) -The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA ...
Dr. Vinay Prasad succeeds Dr. Peter Marks, who left the role of leader of the FDA’s Center for Biologics Evaluation and ...
He succeeds Peter Marks, who oversaw the approval of COVID-19 vaccines and was pushed out ... treatment for Duchenne muscular dystrophy. Pfizer (NYSE:PFE) shares fell 3%. Smaller gene therapy ...
Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...
MedPage Today on MSN6d
In Reversal, FDA Rehires Staff Tasked With Releasing Public RecordsThe FDA has rehired at least some workers tasked with releasing public records generated by the agency's regulatory ...
Today we have two topics, two segments on two topics, cancer and health disparities, two big topics. In a little while, I'm looking forward to welcoming Dr. Kimberly Enard. She will be joining us from ...
DiEM25 would like to dedicate this Europe Day to the person who best exemplifies what Europe has become: unaccountable, ...
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback